DXR

시간 외 거래: 10.39

Daxor Corporation (DXR)

개요 뉴스 가격 이력 토론 예측 배당 이력

Relative Volume:

Daxor Corporation Stock (DXR) Company Profile

Daxor Corporation

Healthcare (1114)

212-330-8500

Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY

최신 SEC 제출 서류

DXR's Discussions on Twitter

Compare DXR vs ISRG, BDX, ALC, MDLN, RMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
DXR Daxor Corporation	10.39	59.61M	503.40K	9.17M	-604.40K	1.8109
ISRG Intuitive Surgical Inc	469.98	167.61B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	158.27	44.35B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	75.26	36.19B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	42.67	34.11B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	226.31	33.24B	5.40B	1.49B	1.78B	10.12

Daxor Corporation Stock (DXR) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2019-05-16	개시	Ascendiant Capital Markets	Buy

Daxor Corporation 주식(DXR)의 최신 뉴스

Daxor Corporation (DXR) 재무 분석

Daxor Corporation (DXR)

Daxor Corporation Stock (DXR) Company Profile

Compare DXR vs ISRG, BDX, ALC, MDLN, RMD

Daxor Corporation Stock (DXR) Upgrades & Downgrades

Daxor Corporation 주식(DXR)의 최신 뉴스

Daxor Corporation (NASDAQ:DXR) Short Interest Update - MarketBeat

Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 - Investing.com

Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 By Investing.com - Investing.com Australia

Daxor (DXR) CMO boosts stake with 5,941-share equity grant - Stock Titan

Macro Review: What is the long term forecast for Daxor Corporation stockEarnings Trend Report & Daily Price Action Insights - baoquankhu1.vn

Institution Moves: What is the earnings history of Daxor CorporationChart Signals & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Daxor Corporation to Showcase Next-Generation Portable - GlobeNewswire

Daxor to showcase next-gen portable BVA at ACC.26 session - TipRanks

Daxor (DXR) Showcases Innovative Blood Volume Analyzer at Major Cardiology Event - GuruFocus

Daxor Corporation Showcases Next-Generation Portable Blood Volume Analyzer At ACC.26 - marketscreener.com

Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions - marketscreener.com

Blood volume test cut heart failure readmissions 56% in studies - Stock Titan

[N-CEN] DAXOR CORP SEC Filing - Stock Titan

Daxor Details Portable FDA-Cleared Blood Volume Analyzer, 'Razor-and-Blades' Kit Growth at iAccess Alpha - MarketBeat

DXR: Direct blood volume analysis drives improved outcomes and rapid revenue growth in a vast market - TradingView

Daxor (DXR) Unveils Portable Blood Volume Analyzer at Critical C - GuruFocus

Daxor Corporation Showcases New Portable Blood Volume Analyzer - marketscreener.com

Daxor to debut portable blood volume analyzer at SCCM Critical Care Congress - TipRanks

ICU blood volume test linked to 66% fewer deaths goes portable - Stock Titan

Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 - GlobeNewswire

Virtual investor conference to feature Daxor CEO’s 30-minute briefing - Stock Titan

Market Overview: Will Murano Global Investments Plc Equity Warrant benefit from rate cuts2026 Top Gainers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

What analyst consensus says on Daxor Corporation stockExit Point & Fast Moving Trade Plans - Naître et grandir

Layoff Watch: Is Daxor Corporation a turnaround storyGap Up & Safe Entry Trade Reports - baoquankhu1.vn

Daxor (NYSEAMERICAN:DXR) Share Price Passes Below 200-Day Moving AverageHere's What Happened - MarketBeat

Analysts Are Bullish on These Healthcare Stocks: Niagen Bioscience (NAGE), Daxor (DXR) - The Globe and Mail

European Stocks Set for Mixed Opening Amid Geopolitical Tensions - Intellectia AI

DXR SEC FilingsDAXOR CORP 10-K, 10-Q, 8-K Forms - Stock Titan

Daxor Corporation Reports 2025 Fiscal Year Results, Operating Revenue Up 45%, Net Asset Value Rises to $9.07 per Share - marketscreener.com

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders - Bitget

Daxor reports 45% revenue growth, plans regulatory shift - Investing.com

Daxor Corporation CEO and President Michael Feldschuh provides corporate update in letter to shareholders - marketscreener.com

Daxor (DXR) Records Strong Growth and Regulatory Changes in 2025 - GuruFocus

Daxor issues update in Letter to Shareholders - TipRanks

Daxor (DXR) Secures FDA Clearance for Advanced Blood Volume Anal - GuruFocus

Daxor Corporation CEO And President Michael Feldschuh Provides Corporate Update In Letter To Shareholders - TradingView

7-pound blood volume analyzer wins FDA clearance, gains hospital users - Stock Titan

Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share - marketscreener.com

Daxor Corporation Reports 2025 Fiscal Year Results: - GlobeNewswire

DXR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

FDA‑cleared BVA boosts momentum; Daxor (NASDAQ: DXR) posts NAV $9.07 and $46M operating valuation - Stock Titan

Daxor Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Short Interest in Daxor Corporation (NASDAQ:DXR) Decreases By 44.0% - MarketBeat

Daxor Corporation (DXR) Competitors - Meyka

Daxor (NASDAQ:DXR) vs. Addus HomeCare (NASDAQ:ADUS) Financial Survey - Defense World

EBIT per share of Daxor Corporation – NASDAQ:DXR - TradingView

Daxor (NYSEAMERICAN:DXR) Share Price Crosses Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Daxor continues strategic expansion, opens new BVA program in Tennessee - TipRanks

Analysts Offer Insights on Healthcare Companies: Daxor (DXR) and HealthStream (HSTM) - The Globe and Mail

Daxor (DXR) Expands BVA Program to Southern Middle Tennessee - GuruFocus

Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee - The Manila Times

Daxor Corporation (DXR) 재무 분석

매출

순이익

현금흐름

주당 순 이익

DXR과 유사한 종목